Williams Jones & Associates’s Harte-Hanks HHS Stock Holding History

Williams Jones & Associates’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,000	Closed	-$9K	–	451
2017 Q4	$9K	Hold	1,000	–	–	﹤0.01%	437
2017 Q3	$11K	Hold	1,000	–	–	﹤0.01%	433
2017 Q2	$10K	Hold	1,000	–	–	﹤0.01%	411
2017 Q1	$14K	Hold	1,000	–	–	﹤0.01%	406
2016 Q4	$15K	Hold	1,000	–	–	﹤0.01%	377
2016 Q3	$16K	Hold	1,000	–	–	﹤0.01%	397
2016 Q2	$16K	Sell	1,000 -710	-42%	-$12.5K	﹤0.01%	390
2016 Q1	$43K	Sell	1,710 -3,100	-64%	-$95.2K	﹤0.01%	344
2015 Q4	$156K	Hold	4,810	–	–	0.01%	327
2015 Q3	$170K	Hold	4,810	–	–	0.01%	333
2015 Q2	$287K	Hold	4,810	–	–	0.01%	310
2015 Q1	$375K	Sell	4,810 -775	-14%	-$59.9K	0.02%	282
2014 Q4	$432K	Sell	5,585 -635	-10%	-$41.5K	0.02%	270
2014 Q3	$396K	Buy	+6,220	New	+$423K	0.02%	230

Other funds holding HHS

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Williams Jones & Associates's HHS Position: Q1 2018 in Review

Williams Jones & Associates sold out of Harte-Hanks (HHS) in Q1 2018, closing a stake of 1,000 shares — an estimated $9K sold.

Williams Jones & Associates first reported a position in HHS in Q3 2014 and held it in 14 quarters. The position peaked at $432K in Q4 2014. 28 funds tracked by Wall St. Rank hold HHS as of Q1 2018.

Williams Jones & Associates reported no remaining Harte-Hanks position as of Q1 2018 after selling out during the quarter.
Williams Jones & Associates sold 1,000 Harte-Hanks shares in Q1 2018, an estimated $9K.
Williams Jones & Associates first reported a position in Harte-Hanks in Q3 2014 and held it in 14 quarters.
Williams Jones & Associates's Harte-Hanks position peaked at $432K in Q4 2014.
28 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2018.

Based on Williams Jones & Associates's 13F filing for Q1 2018, filed 15 May 2018.